Clinical Trial Update: Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease

View source ↗

Summary

This clinical trial update reports on the efficacy and safety of GENOSS SES in patients with coronary artery disease. The study, sponsored by Genoss Co., Ltd., …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• GENOSS SES

Snippet

Sponsor: Genoss Co., Ltd. | Conditions: Coronary Arterial Disease (CAD) | Status: ACTIVE_NOT_RECRUITING